Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation and one minimal function mutation in patients aged 6 to 11 years Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Elafibranor for previously treated primary biliary cholangitis Elafibranor (GFT-505) Primary biliary cholangitis (PBC) Hepatology 2023 View  |  Download
Eladocagene exuparvovec for aromatic l-amino acid decarboxylase deficiency Eladocagene Exuparvo (Upstaza) for Aromatic L-amino acid decarboxylase (AADC) deficiency Aromatic L-amino acid decarboxylase (AADC) deficiency Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
Elacestrant for treating HER2-negative, ER-positive, advanced breast cancer after endocrine therapy Elacestrant Breast cancer Breast Cancer 2022 View  |  Download
Eflornithine with lomustine for treating recurrent anaplastic astrocytoma Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , lomustine Anaplastic astrocytoma Neurological Cancer 2023 View  |  Download
Eflornithine in combination with Sulindac for Familial Adenomatus Polyposis Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , Sulindac Familial adenomatous polyposis (FAP) Gastroenterology , Genetic Disorders 2018 View  |  Download
Eflornithine for treating neuroblastoma Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) Dermatology , Neuroblastoma Bone and Cartilage Cancer 2021 View  |  Download
Efgartigimod PH20 SC for treating chronic inflammatory demyelinating polyradiculoneuropathy Efgartigimod PH20 SC Chronic inflammatory demyelinating polyradiculoneuropathy Neurology 2023 View  |  Download
Efgartigimod PH20 SC for adults with primary immune thrombocytopenia Efgartigimod PH20 SC Immune thrombocytopenia (ITP) Haematology , Immunology 2023 View  |  Download
Efgartigimod alfa for treating pemphigus vulgaris or pemphigus foliaceus Efgartigimod alfa (ARGX-113) Pemphigus foliaceus , Pemphigus vulgaris Dermatology , Immunology 2023 View  |  Download
1 2 80 81 82 83 84 117 118
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications